Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07410988 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Hydroxyethyl Starch Versus Crystalloid and Postoperative Major Adverse Kidney Complications

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Secondary endpoints: details revised at 1 of 4 entriesv5
  2. Recruitment opened Primary completion pushed from Mar 31, 2029 to Jun 30, 2029 · Completion pushed from May 31, 2029 to Jul 31, 2029 · Start date changed from estimate of Jun 1, 2026 to Jun 22, 2026 · 1 morev4 Show 4 more changesShow less
    • Primary completion pushed from Mar 31, 2029 to Jun 30, 2029
    • Completion pushed from May 31, 2029 to Jul 31, 2029
    • Start date changed from estimate of Jun 1, 2026 to Jun 22, 2026
    • Site details revised at 4 of 4 sites
  3. Start date: Apr 1, 2026 to Jun 1, 2026 Secondary endpoints: details revised at 1 of 4 entriesv3 Show 1 more changeShow less
    • Secondary endpoints: details revised at 1 of 4 entries
  4. Primary completion date: Feb 28, 2029 to Mar 31, 2029 Completion date: Mar 31, 2029 to May 31, 2029 · Start date: May 1, 2026 to Apr 1, 2026 · Secondary endpoints: 13 to 4 · 1 morev2 Show 4 more changesShow less
    • Completion date: Mar 31, 2029 to May 31, 2029
    • Start date: May 1, 2026 to Apr 1, 2026
    • Secondary endpoints: 13 to 4
    • Eligibility criteria expanded, about 5 words

    See this version in full on ClinicalTrials.gov ↗

  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This trial aims to compare two intraoperative fluids, namely hydroxyethyl starch (HES) and balanced crystalloids in terms of major adverse kidney events after cardiac surgery. Indications for the study fluids administarion include preload augmentation and intravascular volume replacement during cardiac surgery.
Trial Details
NCT Number NCT07410988
Lead Sponsor Seoul National University Hospital
Conditions Cardiac Surgery
Enrollment 1,292 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov